This will be filed as a serious injury summary report per fda exemption approval number - e2015009.Product performance engineering reviewed the incident information; however, a failure analysis of the complaint device could not be performed because the product was not returned for analysis.A review of the lot history record could not be performed due to unknown lot information.The reported patient effects of intracranial hemorrhage and cerebrovascular accident, as listed in the mitraclip system electronic instructions for use (ifu), are known possible complications associated with mitraclip procedures.A conclusive cause for the reported intracranial hemorrhage and cerebrovascular accident could not be determined.
|
It was reported through transcatheter valve therapy (tvt) registry data that mitraclip devices may be related to 3 intracranial hemorrhage and cerebrovascular accident events which are considered serious injury.The relationship of the adverse events to the mitraclip device could not be determined based on the limited data received from the registry.Patients¿ mean age 70 years, ranging from 62 - 81 years.67% patients were male, 33% patients were female.This will be filed by 7/31/2020 as a serious injury summary report per fda exemption approval number - e2015009.No additional information was provided.
|